KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Brinks (BCO) Cash & Equivalents (2016 - 2025)

Brinks (BCO) has disclosed Cash & Equivalents for 17 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 23.69% to $1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 23.69% increase, with the full-year FY2025 number at $1.7 billion, up 23.69% from a year prior.
  • Cash & Equivalents was $1.7 billion for Q4 2025 at Brinks, up from $461.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.7 billion in Q4 2025 to a low of $274.2 million in Q1 2021.
  • A 5-year average of $710.1 million and a median of $593.4 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 285.77% in 2021, then plummeted 55.81% in 2024.
  • Brinks' Cash & Equivalents stood at $710.3 million in 2021, then plummeted by 38.27% to $438.5 million in 2022, then increased by 15.62% to $507.0 million in 2023, then surged by 175.21% to $1.4 billion in 2024, then rose by 23.69% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BCO's Cash & Equivalents are $1.7 billion (Q4 2025), $461.6 million (Q3 2025), and $525.3 million (Q2 2025).